Identification of preeclampsia by cDNA-gene expression profiling in human placentas and serum - A pilot study;Identifikation von präeklampsiepatientinnen mittels cDNA-genexpressionsprofilen an humanen plazentaproben und serum - Eine Pilotstudie

Zentralblatt fur Gynakologie

Volumn 128, Issue 3, 2006, Pages 138-142

  Ahr, André ^b   Holtrich, U ^a   Karn, T ^a   Reitter, A ^a   Rody, A ^a   Kaufmann, M ^a   Gatje R ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b Gynäkologische Praxis am Ziegelturm ^*  (Germany)

Author keywords

Array; Cluster analysis; Gene expression profiling; Identification; Preeclampsia

Indexed keywords

COMPLEMENTARY DNA;

ARTICLE; BLOOD ANALYSIS; CASE REPORT; CONTROLLED STUDY; DELIVERY; FEMALE; GENE EXPRESSION PROFILING; HUMAN; NUCLEOTIDE SEQUENCE; PLACENTA; PREECLAMPSIA; PREGNANT WOMAN;

ADULT; FEMALE; GENE EXPRESSION PROFILING; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PILOT PROJECTS; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; REPRODUCIBILITY OF RESULTS;

EID: 33745362876     PISSN: 00444197     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-933377     Document Type: Article

References (18)

1. ACOG Committee on Practice Bulletins - Obstetrics: ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Obstet Gynecol 2002; 99: 159-167
2. Ahr A, Holtrich U, Solbach C, Scharl A, Strebhardt K, Karn T, Kaufmann M. Molecular classification of breast cancer patients by gene expression profiling. J Pathol 2001; 195: 312-320
3. Ahr A, Holtrich U, Solbach C, Scharl A, Strebhardt K, Karn T, Kaufmann M. Molekularbiologische Klassifikation von Hochrisiko-Patientinnen beim primären Mammakarzinom durch Genexpressionsanalysen. Geburtsh Frauenheilk 2001; 61: 954-963
4. Ahr A, Kam T, Solbach C, Seiter T, Strebhardt K, Holtrich U, Kaufmann M. Identification of high risk breast-cancer patients by gene expression profiling. Lancet 2002; 359: 131-132
5. Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A, Boldrick JC, Sabet H, Tran T, Yu X, Powell JI, Yang L, Marti GE, Moore T, Hudson Jr J, Lu L, Lewis DB, Tibshirani R, Sherlock G, Chan WC, Greiner TC, Weisenburger DD, Armitage JO, Warnke R, Levy R, Wilson W, Grever MR, Byrd JC, Botstein D, Brown PO, Staudt LM. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000; 403: 503-511
6. Eisen MB, Spellman PT, Brown PO, Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 1998; 95: 14863-14868
7. Fitzpatrick E, Goring HH, Liu H, Borg A, Forrest S, Cooper DW, Brennecke SP, Moses EK. Fine mapping and SNP analysis of positional candidates at the preeclampsia susceptibility locus (PREG1) on chromosome 2. Hum Biol 2004; 76: 849-862
8. Golub TR, Slonim DK, Tamayo P, Huard C, Gaasenbeek M, Mesirov JP, Coller H, Loh ML, Downing JR, Caligiuri MA, Bloomfield CD, Lander ES. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. 1999; 286: 531-537
9. Heikkila A, Tuomisto T, Hakkinen SK, Keski-Nisula L, Heinonen S, Yla-Herttuala S. Tumor suppressor and growth regulatory genes are overexpressed in severe early-onset preeclampsia - an array study on case-specific human preeclamptic placental tissue. Acta Obstet Gynecol Scand 2005; 84: 679-689
10. Ingec M, Gursoy HG, Yildiz L, Kumtepe Y, Kadanali S. Serum levels of insulin, IGF-1, and IGFBP-1 in pre-eclampsia and eclampsia. Int J Gynaecol Obstet 2004; 84: 214-219
11. Lachmeijer AM, Dekker GA, Pals G, Aarnoudse JG, ten Kate LP, Arngrimsson R. Searching for preeclampsia genes: the current position. Eur J Obstet Gynecol Reprod Biol 2002; 105: 94-113
12. Page NM, Woods RJ, Gardiner SM, Lomthaisong K, Gladwell RT, Butlin DJ, Manyonda IT, Lowry PJ. Excessive placental secretion of neurokinin B during the third trimester causes pre-eclampsia. Nature 2000; 405: 797-800
13. Pang ZJ, Xing FQ. Comparative profiling of metabolism-related gene expression in pre-eclamptic and normal pregnancies. Arch Gynecol Obstet 2004; 269: 91-95
14. Pang ZJ, Xing FQ. Comparative study on the expression of cytokine-receptor genes in normal and preeclamptic human placentas using DNA microarrays. J Perinat Med 2003; 31: 153-162
15. Roberts JM, Cooper DW. Pathogenesis and genetics of pre-eclampsia. Lancet 2001; 357: 53-56
16. Tsoi SC, Cale JM, Bird IM, Kay HH. cDNA microarray analysis of gene expression profiles in human placenta: up-regulation of the transcript encoding muscle subunit of glycogen phosphorylase in preeclampsia. J Soc Gynecol Investig 2003; 10: 496-502
17. Tsumagari K, Chijiiwa K, Nagai H, Makita M, Kasumi F, Akiyama F, Sakamoto G, Miki Y. Postoperative prognosis of node-negative breast cancers predicted by gene-expression profiling on a cDNA microarray of 25,344 genes. Breast Cancer 2005; 12: 166-177
18. Walker JJ. Pre-eclampsia. Lancet 2000; 356: 1260-1265